Clinical Trial Update: A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp) [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial evaluating the safety and efficacy of PEP005 Topical Gel for actinic keratoses on the face or scalp; results were posted after study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 Topical Gel (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2012-08-22